Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2Phase NA 1

Status

Completed 3Terminated 2

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Breast Neoplasms 291Carcinoma, Non-Small-Cell Lung 222Neoplasms 193Prostatic Neoplasms 158Multiple Myeloma 138Neoplasm Metastasis 115Melanoma 110Colorectal Neoplasms 107Leukemia, Myeloid, Acute 103Lymphoma 97Lung Neoplasms 94Ovarian Neoplasms 84Squamous Cell Carcinoma of Head and Neck 75Lymphoma, Non-Hodgkin 73Leukemia, Lymphocytic, Chronic, B-Cell 70Pancreatic Neoplasms 64Triple Negative Breast Neoplasms 62Myelodysplastic Syndromes 62Parkinson Disease 4, Autosomal Dominant Lewy Body 59Hematologic Neoplasms 59Head and Neck Neoplasms 59Recurrence 56Glioblastoma 55Leukemia 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Sarcoma 49Brain Neoplasms 49Lymphoma, Large B-Cell, Diffuse 47Carcinoma, Hepatocellular 47Lymphoma, Follicular 45

Interventions

Nivolumab 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Has results × Solid Tumor × 1 year × Clear all
NCT05322408 2025-11-05

HCW9218 in Select Advanced Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Completed
18 enrolled 17 charts
Other solid neoplasm

Solid Tumor

NCT03770494 2025-11-04

A Study of LY3405105 in Participants With Advanced Cancer

Eli Lilly and Company

Phase 1 Terminated
54 enrolled 26 charts
Other solid neoplasm

Solid Tumor

NCT01239381 2025-09-30

Individualized Stereotactic Body Radiotherapy of Liver Metastases

Massachusetts General Hospital

Phase NA Completed
92 enrolled 13 charts
Other solid neoplasm

Solid Tumor

NCT03195478 2025-09-15

A Study of Nivolumab in Combination With Ipilimumab in Chinese Participants With Previously Treated Advanced or Recurrent Solid Tumors

Bristol-Myers Squibb

Phase 1/2 Completed
37 enrolled 32 charts
Other solid neoplasm

Solid Tumor

NCT04455620 2025-07-02

BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors

BioNTech SE

Phase 1/2 Terminated
49 enrolled 19 charts
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡